Locally Advanced Rectal Cancer
- Total neoadjuvant therapy (neoadjuvant chemotherapy and chemoradiation prior to total mesorectal excision)
- Minimally invasive techniques for surgery of rectal cancer (laparoscopy, robotic surgery, and transanal total mesorectal excision)
- A novel PD-1 blocker, dostarlimab, has shown very promising results in a phase 2 trial, current demonstrating a 100% clinical remission rate; further study is required to ascertain if this result lasts








.png)







